Ignite Creation Date:
2024-05-06 @ 5:45 PM
Last Modification Date:
2024-10-26 @ 2:34 PM
Study NCT ID:
NCT05410197
Status:
RECRUITING
Last Update Posted:
2022-10-12
First Post:
2022-06-04
Brief Title:
Envofolimab and Lenvatinib Combined With Gemcitabine Plus Cisplatin for Advanced BTC as First-Line TreatmentENLIGHTEN
Sponsor:
Sun Yat-sen University
Organization:
Sun Yat-sen University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-04
First Submit QC Date:
June 4 2022
Study First Post Date:
2022-06-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-10-11
Last Update Post Date:
2022-10-12
Last Update Post Date Type:
ACTUAL